Do the Advantages of the FiberNet(®) Embolic Protection Device Translate into Technical Success and Comparable Event...

Area of Science:

• Interventional Cardiology
• Vascular Surgery
• Medical Device Technology

Background:

• The FiberNet(®) device is a novel embolization protection device (EPD) designed for carotid artery stenting (CAS).
• It offers potential advantages in capturing smaller debris, flexibility in curved vessels, and improved deliverability.
• Concerns exist regarding potential flow obstruction and aspiration requirements during device retrieval.

Purpose of the Study:

• To compare the technical success and adverse event rates of CAS using FiberNet(®) versus other filter-based EPDs.
• To evaluate the safety and efficacy of FiberNet(®) in a real-world clinical setting.

Main Methods:

• A retrospective comparison of 25 patients treated with FiberNet(®) against 250 patients treated with other EPDs across multiple centers.
• Data collected included patient demographics, lesion characteristics, procedural success, and 30-day outcomes (TIA, CVA, death).
• Statistical analysis included chi-square tests, means comparison, and bivariate logistic regression.

Main Results:

• Procedural success was 100% in both the FiberNet(®) and comparison groups.
• No stagnant flow was observed in the FiberNet(®) group.
• Thirty-day outcomes for TIA, CVA, or death were similar: 4% for FiberNet(®) versus 4.8% for the comparison group (p NS).
• FiberNet(®) patients had more lesion calcification and complex arch anatomy but comparable adverse event rates.

Conclusions:

• FiberNet(®) achieves excellent technical success and comparable safety profiles to existing EPDs in CAS.
• Despite challenging patient and lesion characteristics, FiberNet(®) proved effective.
• FiberNet(®) is a promising EPD for high-risk CAS procedures, offering advantages in specific challenging scenarios.